718 related articles for article (PubMed ID: 29174549)
1. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
2. Proteome-wide subtractive approach to prioritize a hypothetical protein of XDR-Mycobacterium tuberculosis as potential drug target.
Uddin R; Siddiqui QN; Sufian M; Azam SS; Wadood A
Genes Genomics; 2019 Nov; 41(11):1281-1292. PubMed ID: 31388979
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.
Kanji A; Hasan R; Ali A; Zaver A; Zhang Y; Imtiaz K; Shi W; Clark TG; McNerney R; Phelan J; Rao S; Shafiq S; Hasan Z
Tuberculosis (Edinb); 2017 Dec; 107():20-30. PubMed ID: 29050768
[TBL] [Abstract][Full Text] [Related]
4. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
Uddin R; Zahra NU; Azam SS
Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Igarashi Y; Chikamatsu K; Aono A; Yi L; Yamada H; Takaki A; Mitarai S
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):276-281. PubMed ID: 28974394
[TBL] [Abstract][Full Text] [Related]
7. Differential DNA methylomes of clinical MDR, XDR and XXDR
Gong Z; Wang G; Zeng J; Stojkoska A; Huang H; Xie J
J Drug Target; 2021 Jan; 29(1):69-77. PubMed ID: 32672115
[TBL] [Abstract][Full Text] [Related]
8. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
10. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
[TBL] [Abstract][Full Text] [Related]
11. An
Kumar S; Sahu P; Jena L
Int J Mycobacteriol; 2019; 8(3):252-261. PubMed ID: 31512601
[TBL] [Abstract][Full Text] [Related]
12. Study of promoter and structural gene sequence of whiB7 in MDR and XDR forms of Mycobacterium tuberculosis.
Arjomandzadegan M; Sadrnia M; Surkova LK; Titov LP
West Indian Med J; 2011 Jun; 60(3):251-6. PubMed ID: 22224334
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
14. A systemic approach to explore the mechanisms of drug resistance and altered signaling cascades in extensively drug-resistant tuberculosis.
Udhaya Kumar S; Saleem A; Thirumal Kumar D; Anu Preethi V; Younes S; Zayed H; Tayubi IA; George Priya Doss C
Adv Protein Chem Struct Biol; 2021; 127():343-364. PubMed ID: 34340773
[TBL] [Abstract][Full Text] [Related]
15. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796
[TBL] [Abstract][Full Text] [Related]
16. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia.
Ilina EN; Shitikov EA; Ikryannikova LN; Alekseev DG; Kamashev DE; Malakhova MV; Parfenova TV; Afanas'ev MV; Ischenko DS; Bazaleev NA; Smirnova TG; Larionova EE; Chernousova LN; Beletsky AV; Mardanov AV; Ravin NV; Skryabin KG; Govorun VM
PLoS One; 2013; 8(2):e56577. PubMed ID: 23437175
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis.
Chaiyachat P; Kaewseekhao B; Chaiprasert A; Kamolwat P; Nonghanphithak D; Phetcharaburanin J; Sirichoat A; Ong RT; Faksri K
Sci Rep; 2023 May; 13(1):8655. PubMed ID: 37244948
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacterium tuberculosis.
Kashyap A; Singh PK; Silakari O
Drug Metab Rev; 2018 Nov; 50(4):448-465. PubMed ID: 30343607
[TBL] [Abstract][Full Text] [Related]
20. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand.
Disratthakit A; Meada S; Prammananan T; Thaipisuttikul I; Doi N; Chaiprasert A
Infect Genet Evol; 2015 Jun; 32():432-9. PubMed ID: 25847698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
